In July 2019, a jury awarded $229.6 million in the largest medical malpractice verdict ever in the United States.
Successfully navigating the professional liability environment in ob/gyn can be difficult, especially amid a global pandemic. Liability issues and malpractice claims continue to increase, which may call for a shift in the ways of ob/gyn practice.
In July 2019, a jury awarded $229.6 million in the largest medical malpractice verdict ever in the United States1. In that case, her provider said she could terminate the pregnancy because the baby was non-viable. As a result, the patient declined a C-section and her provider stopped monitoring the fetus. With insufficient levels of oxygen to the brain, the baby was born with brain damage2.
Four months later, another jury award of $229.6 million was settled3. According to local news sources, the infant suffered brain damage after an emergency C-section was not performed3.
As Vice President of Risk Management, Quality, and Compliance for the nation’s largest ob/gyn hospitalist organization, Heather Moore discusses the issues surrounding medical malpractice claims and identifies key risk mitigation strategies in a recent article from Medical Economics.
Moore advises ob/gyns and hospital systems to be proactive, saying that hospitals should take steps to address risk mitigation and quality control. Doing so can significantly decrease the likelihood of a successful medical malpractice claim.
Moore also discusses a 2016 study by Ob Hospitalist Group that aimed to identify key risk mitigation strategies that resulted in significant claims reductions. They found that a 31% reduction in perinatal serious-harm events at hospitals was associated with one factor: the implementation of an OB hospitalist program.
Gain additional insight and expertise into medical malpractice claims and risk reduction in Moore’s article for Medical Economics,‘The evolving liability landscape and obstetrical care.’
__
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More